glp-1 for inflammation Antiinflammatory actions of glucagon-like peptide-1–based therapies beyond metabolic benefits Everyone is talking about GLP-1s

Individuals with a History of Pancreatitis : Due to the potential for an increased risk of pancreatitis, GLP-1 is contraindicated in individuals with a history of this condition or other pancreatic disorders

Ill share a new update on Thursday

Mark the vial with the opening date and a discard date (28 days from opening) to ensure its integrity

This SLR identified only one study formally assessing treatment sequencing (RECAP), in which no significant difference in kidney outcomes was observed, based on whether SGLT2i or GLP-1 RA therapy was initiated first [17]

Subcutaneous administration into the fatty tissue beneath the skin, allows for a more sustained release of the peptide into the bloodstream